{"DataElement":{"publicId":"7799236","version":"1","preferredName":"Treatment Cohort Study 10402 Code","preferredDefinition":"The code that represents the information pertaining to protocol 10402 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_10402_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7799221","version":"1","preferredName":"10402 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"7799221v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"TAC10","valueDescription":"TAC10: BAY1895344 60mg D2,5 + Topotecan 1.25mg/m2","ValueMeaning":{"publicId":"7799222","version":"1","preferredName":"TAC10: BAY1895344 60mg D2,5 + Topotecan 1.25mg/m2","longName":"7799222","preferredDefinition":"TAC10: BAY1895344 60mg D2,5 + Topotecan 1.25mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BD0E-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BD27-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC9","valueDescription":"TAC9: BAY1895344 40mg D2,5 + Topotecan 1.25mg/m2","ValueMeaning":{"publicId":"7799223","version":"1","preferredName":"TAC9: BAY1895344 40mg D2,5 + Topotecan 1.25mg/m2","longName":"7799223","preferredDefinition":"TAC9: BAY1895344 40mg D2,5 + Topotecan 1.25mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BD31-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BD4A-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC7B","valueDescription":"TAC7B: BAY1895344 80mg D2 + Topotecan 1.25mg/m2","ValueMeaning":{"publicId":"7799224","version":"1","preferredName":"TAC7B: BAY1895344 80mg D2 + Topotecan 1.25mg/m2","longName":"7799224","preferredDefinition":"TAC7B: BAY1895344 80mg D2 + Topotecan 1.25mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BD54-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BD6D-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC7A","valueDescription":"TAC7A: BAY1895344 60mg D2 + Topotecan 1mg/m2","ValueMeaning":{"publicId":"7799225","version":"1","preferredName":"TAC7A: BAY1895344 60mg D2 + Topotecan 1mg/m2","longName":"7799225","preferredDefinition":"TAC7A: BAY1895344 60mg D2 + Topotecan 1mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BD77-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BD90-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC8","valueDescription":"TAC8: BAY1895344 40mg D2,5 + Topotecan 1mg/m2","ValueMeaning":{"publicId":"7799226","version":"1","preferredName":"TAC8: BAY1895344 40mg D2,5 + Topotecan 1mg/m2","longName":"7799226","preferredDefinition":"TAC8: BAY1895344 40mg D2,5 + Topotecan 1mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BD9A-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BDB3-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC7","valueDescription":"TAC7: BAY1895344 20mg D2,5 + Topotecan 1mg/m2","ValueMeaning":{"publicId":"7799227","version":"1","preferredName":"TAC7: BAY1895344 20mg D2,5 + Topotecan 1mg/m2","longName":"7799227","preferredDefinition":"TAC7: BAY1895344 20mg D2,5 + Topotecan 1mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BDBD-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BDD6-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC6","valueDescription":"TAC6: BAY1895344 10mg D2,5 + Topotecan 1mg/m2","ValueMeaning":{"publicId":"7799228","version":"1","preferredName":"TAC6: BAY1895344 10mg D2,5 + Topotecan 1mg/m2","longName":"7799228","preferredDefinition":"TAC6: BAY1895344 10mg D2,5 + Topotecan 1mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BDE0-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BDF9-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC3B","valueDescription":"TAC3B: BAY1895344 80mg D2 + Irinotecan 180mg/m2","ValueMeaning":{"publicId":"7799229","version":"1","preferredName":"TAC3B: BAY1895344 80mg D2 + Irinotecan 180mg/m2","longName":"7799229","preferredDefinition":"TAC3B: BAY1895344 80mg D2 + Irinotecan 180mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BE03-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BE1C-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC3A","valueDescription":"TAC3A: BAY1895344 60mg D2 + Irinotecan 180mg/m2","ValueMeaning":{"publicId":"7799230","version":"1","preferredName":"TAC3A: BAY1895344 60mg D2 + Irinotecan 180mg/m2","longName":"7799230","preferredDefinition":"TAC3A: BAY1895344 60mg D2 + Irinotecan 180mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BE26-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BE3F-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC5","valueDescription":"TAC5: BAY1895344 60mg D1,2 + Irinotecan 180mg/m2","ValueMeaning":{"publicId":"7799231","version":"1","preferredName":"TAC5: BAY1895344 60mg D1,2 + Irinotecan 180mg/m2","longName":"7799231","preferredDefinition":"TAC5: BAY1895344 60mg D1,2 + Irinotecan 180mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BE49-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BE62-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC4","valueDescription":"TAC4: BAY1895344 40mg D1,2 + Irinotecan 180mg/m2","ValueMeaning":{"publicId":"7799232","version":"1","preferredName":"TAC4: BAY1895344 40mg D1,2 + Irinotecan 180mg/m2","longName":"7799232","preferredDefinition":"TAC4: BAY1895344 40mg D1,2 + Irinotecan 180mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BE6C-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BE85-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC3","valueDescription":"TAC3: BAY1895344 20mg D1,2 + Irinotecan 180mg/m2","ValueMeaning":{"publicId":"7799233","version":"1","preferredName":"TAC3: BAY1895344 20mg D1,2 + Irinotecan 180mg/m2","longName":"7799233","preferredDefinition":"TAC3: BAY1895344 20mg D1,2 + Irinotecan 180mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BE8F-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BEA8-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC2","valueDescription":"TAC2: BAY1895344 20mg D1,2 + Irinotecan 150mg/m2","ValueMeaning":{"publicId":"7799234","version":"1","preferredName":"TAC2: BAY1895344 20mg D1,2 + Irinotecan 150mg/m2","longName":"7799234","preferredDefinition":"TAC2: BAY1895344 20mg D1,2 + Irinotecan 150mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BEB2-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BECB-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC1","valueDescription":"TAC1: BAY1895344 10mg D1,2 + Irinotecan 150mg/m2","ValueMeaning":{"publicId":"7799235","version":"1","preferredName":"TAC1: BAY1895344 10mg D1,2 + Irinotecan 150mg/m2","longName":"7799235","preferredDefinition":"TAC1: BAY1895344 10mg D1,2 + Irinotecan 150mg/m2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BED5-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEDBB371-BEEE-08DA-E053-4EBD850AE0AB","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"ONEDATA","dateModified":"2021-10-21","deletedIndicator":"No"},{"value":"TAC11","valueDescription":null,"ValueMeaning":{"publicId":"10425444","version":"1","preferredName":"TAC11: BAY 1895344 10 mg QD D2,5+Topotecan 0.5 mg/m2 D1-5","longName":"10425444v1.00","preferredDefinition":"TAC11: BAY 1895344 10 mg QD D2,5+Topotecan 0.5 mg/m2 D1-5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-66DE-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-06-07","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC1DD82-66E0-2FB8-E053-731AD00AE15F","beginDate":"2022-06-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-06-07","modifiedBy":"SOKKERL","dateModified":"2022-06-07","deletedIndicator":"No"},{"value":"TAC12","valueDescription":null,"ValueMeaning":{"publicId":"10425445","version":"1","preferredName":"TAC12: BAY 1895344 10 mg QD D2,5+Topotecan 0.75 mg/m2 D1-5","longName":"10425445v1.00","preferredDefinition":"TAC12: BAY 1895344 10 mg QD D2,5+Topotecan 0.75 mg/m2 D1-5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-66DF-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-06-07","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC1DD82-66E1-2FB8-E053-731AD00AE15F","beginDate":"2022-06-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-06-07","modifiedBy":"SOKKERL","dateModified":"2022-06-07","deletedIndicator":"No"},{"value":"TAC13","valueDescription":null,"ValueMeaning":{"publicId":"10425448","version":"1","preferredName":"TAC13: BAY 1895344 20 mg QD D2,5+Topotecan 0.75 mg/m2 D1-5","longName":"10425448v1.00","preferredDefinition":"TAC13: BAY 1895344 20 mg QD D2,5+Topotecan 0.75 mg/m2 D1-5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-66E4-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-06-07","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC1DD82-66E6-2FB8-E053-731AD00AE15F","beginDate":"2022-06-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-06-07","modifiedBy":"SOKKERL","dateModified":"2022-06-07","deletedIndicator":"No"},{"value":"TAC14","valueDescription":null,"ValueMeaning":{"publicId":"10425449","version":"1","preferredName":"TAC14: BAY 1895344 20 mg QD D2,5+Topotecan 1 mg/m2 D1-5","longName":"10425449v1.00","preferredDefinition":"TAC14: BAY 1895344 20 mg QD D2,5+Topotecan 1 mg/m2 D1-5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC1DD82-66E5-2FB8-E053-731AD00AE15F","latestVersionIndicator":"Yes","beginDate":"2022-06-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-06-07","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC1DD82-66E7-2FB8-E053-731AD00AE15F","beginDate":"2022-06-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-06-07","modifiedBy":"SOKKERL","dateModified":"2022-06-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBB371-BCF7-08DA-E053-4EBD850AE0AB","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2022-06-07","changeDescription":"10/21/21 LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Please select the cohort","type":"Preferred Question Text","description":"Please select the cohort","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEDBBCBA-19B3-3335-E053-4EBD850ADD4C","latestVersionIndicator":"Yes","beginDate":"2021-10-21","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-21","modifiedBy":"SOKKERL","dateModified":"2021-10-21","changeDescription":"10/21/21 LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}